Abstract
ENWEndNote BIBJabRef, Mendeley RISPapers, Reference Manager, RefWorks, Zotero AMA Czeremszyńska B, Bujko M, Ibron G, Onap-Karnak A, Nawrocki S. Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre. Contemporary Oncology/Współczesna Onkologia. 2011;15(4):198-202. doi:10.5114/wo.2011.24313. APA Czeremszyńska, B., Bujko, M., Ibron, G., Onap-Karnak, A., & Nawrocki, S. (2011). Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre. Contemporary Oncology/Współczesna Onkologia, 15(4), 198-202. https://doi.org/10.5114/wo.2011.24313 Chicago Czeremszyńska, Beata, Mateusz Bujko, Grażyna Ibron, Agnieszka Onap-Karnak, and Sergiusz Nawrocki. 2011. "Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre". Contemporary Oncology/Współczesna Onkologia 15 (4): 198-202. doi:10.5114/wo.2011.24313. Harvard Czeremszyńska, B., Bujko, M., Ibron, G., Onap-Karnak, A., and Nawrocki, S. (2011). Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre. Contemporary Oncology/Współczesna Onkologia, 15(4), pp.198-202. https://doi.org/10.5114/wo.2011.24313 MLA Czeremszyńska, Beata et al. "Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre." Contemporary Oncology/Współczesna Onkologia, vol. 15, no. 4, 2011, pp. 198-202. doi:10.5114/wo.2011.24313. Vancouver Czeremszyńska B, Bujko M, Ibron G, Onap-Karnak A, Nawrocki S. Treatment results, including clinical prognostic factors and MGMT gene promoter methylation, in patients with glioblastoma multiforme in Warmia and Mazury Oncology Centre. Contemporary Oncology/Współczesna Onkologia. 2011;15(4):198-202. doi:10.5114/wo.2011.24313.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
